CHARTWELL RX FDA Approval ANDA 088596

ANDA 088596

CHARTWELL RX

FDA Drug Application

Application #088596

Documents

Review1999-04-13

Application Sponsors

ANDA 088596CHARTWELL RX

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL37.5MG0PHENTERMINE HYDROCHLORIDEPHENTERMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1984-04-04
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1986-05-22
LABELING; LabelingSUPPL5AP1989-06-15
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1988-06-27
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1988-06-27
LABELING; LabelingSUPPL8AP1989-06-15
LABELING; LabelingSUPPL9AP1989-12-15
LABELING; LabelingSUPPL10AP1990-05-24
LABELING; LabelingSUPPL11AP1991-01-31
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1992-10-16
LABELING; LabelingSUPPL14AP1997-12-19
LABELING; LabelingSUPPL15AP1998-04-08
LABELING; LabelingSUPPL16AP1998-08-19
LABELING; LabelingSUPPL17AP1998-11-03
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2000-07-26

Submissions Property Types

SUPPL2Null0
SUPPL6Null0
SUPPL7Null0
SUPPL13Null0
SUPPL18Null0

CDER Filings

CHARTWELL RX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88596
            [companyName] => CHARTWELL RX
            [docInserts] => ["",""]
            [products] => [{"drugName":"PHENTERMINE HYDROCHLORIDE","activeIngredients":"PHENTERMINE HYDROCHLORIDE","strength":"37.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PHENTERMINE HYDROCHLORIDE","submission":"PHENTERMINE HYDROCHLORIDE","actionType":"37.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.